About Virchow Biotech Private Limited
Data last updated:
Virchow Biotech Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 04 April 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24210TG2001PTC036520. Its GSTIN is 36AABCV2578A1ZI (Telangana). The company holds 6 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹20.5 Cr and a paid-up capital of ₹17.03 Cr. It is led by directors including Tummuru Murali Krishna Reddy (Managing Director) and Hemanth Nandigala (Managing Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.4 Sv Co Op Industrial Estate Ida Jeedimetla, Hyderabad, Telangana, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹758.21 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹77.65 Cr (net margin 10.2%) and EBITDA of ₹135.97 Cr (EBITDA margin 17.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 17% over five years.
The company has about 1,048 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand: Virchow Biotech. As per MCA filings, the company has open charges of ₹190.8 Cr and satisfied charges of ₹144.71 Cr on record. Court records list 42 cases involving the company, including 22 filed by the company and 20 filed against it; 14 cases are pending. The company has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹23.48 Cr; the latest was in March 2017. Its 3 peer companies in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is Reliance Life Sciences Private Limited with revenue of ₹2,615.3 Cr.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website virchowbiotech.com.
Company details
CIN history
Virchow Biotech has one previous CIN (Corporate Identification Number): U24210AP2001PTC036520. The current CIN is U24210TG2001PTC036520, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24210TG2001PTC036520 | Current |
| U24210AP2001PTC036520 | Previous |
Contact details
Virchow Biotech Private Limited's registered office is in Hyderabad, Telangana. Its website is virchowbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.4 Sv Co Op Industrial Estate Ida Jeedimetla, Hyderabad, Telangana, India
- IndustryLife Sciences, Biotechnology
To see the full contact details of Virchow Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Virchow Biotech operates one associated brand: Virchow Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Recombinant biologicals for wound care and bone disorders are developed. | virchowbiotech.com |
Business activity
The main business activity of Virchow Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Virchow Biotech Private Limited, buy the company report.
Financials of Virchow Biotech Private Limited
FY 2025 filings availableVirchow Biotech Private Limited reported revenue of ₹758.21 Cr (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 5% growth in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹135.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹77.65 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.9% | ||||
| Net Profit Margin | 10.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Virchow Biotech Private Limited, buy the company report.
Board of directors of Virchow Biotech Private Limited
Virchow Biotech has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tummuru Murali Krishna Reddy | Managing Director | 22 Nov 2001 | 24 Years 11 Months | Current |
| Prasanth Nandigala | Director | 04 Jan 2024 | 2 Years 9 Months | Current |
| Mundla Maha Vishnu Also directs: Virchow Laboratories Limited, Saraca Laboratories Limited, Ceph Lifesciences Private Limited and 5 more | Director | 04 Jan 2024 | 2 Years 9 Months | Current |
| Hemanth Nandigala Also directs: Virchow Healthcare Private Limited, Virchow Laboratories Limited, Virchowtech Vaccines & Biologics Private Limited and 1 more | Managing Director | 04 Apr 2001 | 25 Years 6 Months | Current |
Peer comparison
Virchow Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Reliance Life Sciences Private Limited | ₹2,615.3 Cr (FY 2025) | 15.0% | Navi Mumbai, Maharashtra, India | |||
| Bharat Serums and Vaccines Limited | ₹1,455.29 Cr (FY 2023) | 15.0% | Mumbai, Maharashtra, India | |||
| Virchow Biotech Private Limitedthis company | ₹758.21 Cr (FY 2025) | ₹77.65 Cr | 10.2% | 5.0% | 1,048 | Hyderabad, Telangana, India |
| Q-Line Biotech Limited | ₹321.97 Cr (FY 2025) | 56.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Virchow Biotech Private Limited, buy the company report.
Auditor
Virchow Biotech Private Limited is audited by C S V R & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C S V R & ASSOCIATES | FY 2023 | 012121S |
Shareholding
The shareholding of Virchow Biotech Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Virchow Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Dec 2024 | 101023020 | Citi Bank N.A. | ₹10 Cr | Open | |
| 31 Oct 2022 | 100674755 | Hdfc Bank Limited | ₹79.78 Lakh | Open | |
| 11 Apr 2017 | 100142984 | Citi Bank N.A. | ₹180 Cr | Open | |
| 08 Sep 2021 | 100495128 | Hdfc Bank Limited | ₹49 Cr | Satisfied | |
| 03 Apr 2019 | 100260549 | Citi Bank N.A. | ₹50 Cr | Satisfied |
To see the full charge records of Virchow Biotech Private Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Virchow Biotech Private Limited has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹23.48 Cr; the latest was in March 2017.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 3 individuals |
| Mar 2014 | Funding round | ₹5 Cr | Investors: Virchow Laboratories Limited , 3 individuals |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Virchow Laboratories Limited , 2 individuals |
| Oct 2009 | Funding round | ₹17.58 Cr | Investors: Virchow Laboratories Limited |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: Virchow Laboratories Limited Seller: 3 individuals |
To see the full deal history of Virchow Biotech Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Virchow Biotech Private Limited has 42 court cases on record: 22 filed by Virchow Biotech, 20 filed against it. 14 cases are pending and 28 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 26 | 10 | 9 |
| District courts | 16 | 10 | 5 |
Cases on record (5 of 42)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by Om Trans Logistics Limited | Pending |
| High Court, TELANGANA | Revision petition | Filed against the company by M/S.Shasta Freight Services Pvt Ltd | Pending |
| District court, Rangareddy, Telangana | Execution petition | Filed against the company by M/S Shasta Freight Services Pvt Ltd Rep by Srinivas Karra | Pending |
| High Court, Kerala | Writ petition | Filed by the company against The Kerala Medical Services Corporation Ltd., and 1 other | Pending |
| High Court, TAMIL NADU | Original application | Filed against the company by Relish Snacks Pvt Ltd., | Pending |
To see the full case history of Virchow Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Virchow Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Virchow Biotech has 2 subsidiary companies. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Solmed Lifesciences Private Limited | U24239TG2019PTC136292 | |
| Virchow Devices Private Limited | U33100TG2019PTC137918 |
To see the full group structure of Virchow Biotech Private Limited, buy the company report.
Employees & EPFO
Virchow Biotech Private Limited has a workforce of 1,048 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Virchow Biotech has 6 GST registrations: 4 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCV2578A1ZI | Telangana | Active | 01 Jul 2017 |
| 07AABCV2578A1ZJ | Delhi | Active | 09 Jun 2019 |
| 27AABCV2578A1ZH | Maharashtra | Active | 10 Jun 2019 |
| 19AABCV2578A1ZE | West Bengal | Active | 15 Jun 2019 |
To see the full GST registrations and return filing status of Virchow Biotech Private Limited, buy the company report.
Recent activity
Virchow Biotech Private Limited has 11 board changes on record since 2001: 4 appointments and 7 cessations. The latest: Mundla Maha Vishnu ceased to be Additional Director on 29 Sep 2024.
28 earlier events are in the company report.
Frequently asked questions
Virchow Biotech is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 04 April 2001 (25+ years old) and is registered under CIN U24210TG2001PTC036520.
Virchow Biotech has 4 current directors:
- Tummuru Murali Krishna Reddy - Managing Director
- Hemanth Nandigala - Managing Director
- Prasanth Nandigala - Director
- Mundla Maha Vishnu - Director
The latest financial statements of Virchow Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Virchow Biotech is 36AABCV2578A1ZI, registered in Telangana. The company has 6 GST registrations in all, of which 4 are active and 2 are cancelled or inactive. Other active GSTINs include 07AABCV2578A1ZJ (Delhi), 27AABCV2578A1ZH (Maharashtra), 19AABCV2578A1ZE (West Bengal).
The CIN (Corporate Identification Number) of Virchow Biotech is U24210TG2001PTC036520. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Virchow Biotech has 42 court cases on record: 22 filed by the company and 20 filed against it. 14 are pending. Most are in the high courts.
Virchow Biotech was incorporated on 04 April 2001, making it 25+ years old. It is registered with the Registrar of Companies, Hyderabad.
Virchow Biotech has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹23.48 Cr; the latest was in March 2017.
The peers of Virchow Biotech by revenue are Reliance Life Sciences Private Limited, Bharat Serums and Vaccines Limited, Q-Line Biotech Limited, all in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mundla Maha Vishnu ceased to be Additional Director on 29 Sep 2024. Prasanth Nandigala ceased to be Additional Director on 29 Sep 2024. Mundla Maha Vishnu was appointed as Director on 04 Jan 2024. Virchow Biotech has 11 board changes on record in total.
Virchow Biotech can be reached through the website virchowbiotech.com. Its registered office is in Hyderabad, Telangana, India.